Published in J Gen Virol on March 01, 1989
Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophages. PLoS Pathog (2013) 0.93
Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. Nucleic Acids Res (1991) 0.86
Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J Virol (1994) 0.81
Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J Virol (1991) 0.81
Newcastle disease virus infection in chicken embryonic fibroblasts but not duck embryonic fibroblasts is associated with elevated host innate immune response. Virol J (2016) 0.78
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci U S A (1989) 2.54
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res (2001) 1.86
Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood monocytes. Eur J Immunol (2001) 1.42
MN1 overexpression is an important step in the development of inv(16) AML. Leukemia (2007) 1.35
Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol (1981) 1.25
Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res (1999) 1.24
Organization, structure and expression of murine interferon alpha genes. Nucleic Acids Res (1985) 1.24
Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection. J Gen Virol (1982) 1.18
The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol (2000) 1.18
The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J Infect Dis (1982) 1.16
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. J Pathol (2007) 1.14
An X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1. J Gen Virol (1982) 1.08
Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology (1989) 1.08
Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183). Hum Genet (1995) 1.06
Regional localization of over 300 loci on human chromosome 22 using a somatic cell hybrid mapping panel. Genomics (1996) 1.05
Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection. Cancer Gene Ther (2012) 1.05
Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet (2000) 1.04
Identification of individual interferon-producing cells by in situ hybridization. Proc Natl Acad Sci U S A (1985) 1.04
Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum. Eur J Immunol (1980) 1.02
Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J Gen Virol (1981) 1.02
Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C57BL/6 mice. J Gen Virol (1982) 0.99
Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol (1995) 0.97
Interferon production in the murine mixed lymphocyte culture. I. Interferon production caused by differences in the H-2 K and H-2 D region but not by differences in the I region or the M locus. Eur J Immunol (1979) 0.97
Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res (2001) 0.97
Resistance of nude mice to herpes simplex virus and correlation with in vitro production of interferon. Cell Immunol (1979) 0.94
Interferon expression in the testes of transgenic mice leads to sterility. J Biol Chem (1988) 0.93
Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene (1986) 0.93
No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. Br J Cancer (1991) 0.92
Isolation and characterization of 25 unique DNA markers for human chromosome 22. Genomics (1993) 0.92
Production of high titers of interferon-gamma by prestimulated murine spleen cells. Eur J Immunol (1982) 0.89
Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice. J Gen Virol (1983) 0.89
FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo. Br J Dermatol (2008) 0.88
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol (1994) 0.88
IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung. J Mol Endocrinol (1995) 0.88
A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. Am J Hum Genet (1991) 0.88
The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription. Oncogene (2007) 0.87
Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo. Endocrinology (1999) 0.86
The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene (1995) 0.86
Gene expression of the insulin-like growth factor system during mouse kidney development. Mol Cell Endocrinol (1997) 0.86
E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res (1994) 0.85
Structural aspects of the IGFBP family. Growth Regul (1992) 0.85
A G-->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2. Hum Mol Genet (1998) 0.85
Properties of natural and hybrid murine alpha interferons. J Gen Virol (1986) 0.85
Studies of the producer cell of interferon in human lymphocyte cultures. Immunobiology (1979) 0.85
cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. Mol Cell Endocrinol (1994) 0.85
Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons. J Interferon Res (1988) 0.85
Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer (2001) 0.84
A new polymorphic probe on chromosome 22: NB17 (D22S181). Nucleic Acids Res (1991) 0.83
Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta. Cell Immunol (1990) 0.83
Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2. Immunobiology (1987) 0.83
Virus-vs endotoxin-induced activation of liver macrophages. Eur J Biochem (1990) 0.83
Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. Br J Cancer (1999) 0.82
Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. J Gen Virol (1985) 0.82
Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol (1995) 0.82
Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Int J Cancer (1998) 0.81
Production of interferon in the murine mixed lymphocyte culture. II. Interferon production is a T cell-dependent function, independent of proliferation. Eur J Immunol (1979) 0.81
Truncated NF2 proteins are not detected in meningiomas and schwannomas. Neuropathology (2001) 0.81
Gene expression of the IGF binding proteins during post-implantation embryogenesis of the mouse; comparison with the expression of IGF-I and -II and their receptors in rodent and human. Adv Exp Med Biol (1993) 0.81
Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J Virol (1994) 0.81
Constitutional DNA-level aberrations in chromosome 22 in a patient with multiple meningiomas. Genes Chromosomes Cancer (1994) 0.80
mRNA expression patterns of the IGF system during mouse limb bud development, determined by whole mount in situ hybridization. Mol Cell Endocrinol (1998) 0.80
Role of natural killer cells and of interferon in natural resistance against virus infections. Adv Exp Med Biol (1982) 0.80
Gene expression of the six insulin-like growth factor binding proteins in the mouse conceptus during mid- and late gestation. Endocrinology (1993) 0.80
Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures. Int J Oncol (1999) 0.80
Characterization of four novel CAG repeat-containing cDNAs. Genomics (1995) 0.80
Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity. Mol Endocrinol (1991) 0.79
Constitutive expression of a murine interferon alpha gene in hamster cells and characterization of its protein product. J Gen Virol (1985) 0.79
Structure-function analysis of mouse interferon alpha species: MuIFN-alpha 10, a subspecies with low antiviral activity. J Gen Virol (1988) 0.78
The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer. J Pathol (2001) 0.78
Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics. Int J Cancer (1993) 0.78
Two domains in alpha interferons influence the efficacy of the antiviral response. Biochem Biophys Res Commun (1987) 0.78
In vitro production of immune interferon by spleen cells of mice immunized with herpes simplex virus. Cell Immunol (1978) 0.77
An X-linked locus influences early serum interferon levels in the mouse. J Interferon Res (1983) 0.77
Interferon-alpha-(IFN) producing CHO cell lines are resistant to the antiproliferative activity of IFN: a correlation with gene expression. J Cell Biochem (1988) 0.77
Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein. J Neurosci Res (2000) 0.77
Modulation of intra-epithelial expansion of human T24 bladder-carcinoma cells in murine urothelium by growth factors and extracellular-matrix components. Int J Cancer (1995) 0.77
An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins. J Pathol (1994) 0.77
Site-directed mutagenesis of the N-terminal region of IGF binding protein 1; analysis of IGF binding capability. FEBS Lett (1991) 0.77
The biological activity of interferon alpha is influenced by two distinct regions in the protein. Biochem Biophys Res Commun (1989) 0.77
In vitro development of bone-marrow-derived macrophages. Influence of mouse genotype on response to colony-stimulating factors and autocrine interferon induction. Scand J Immunol (1989) 0.77
Expression of the neurofibromatosis type 2 gene in human tissues. J Histochem Cytochem (1999) 0.77
The IGF system during fetal-placental development of the mouse. Mol Cell Endocrinol (1998) 0.76
Expression of the MN1-TEL fusion protein in the human UCSD/AML1 leukemic cell line. Leukemia (2004) 0.76
Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch Virol (1982) 0.76
Absence of BRAF and HRAS mutations in eruptive Spitz naevi. Br J Dermatol (2011) 0.76
On the role of endogenous interferon in natural and induced antiviral resistance. Antiviral Res (1985) 0.76
In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells. Cancer Immunol Immunother (1993) 0.76
Absence of TERT promoter mutations in esophageal adenocarcinoma. Int J Cancer (2014) 0.76
Localization of the epitope of a monoclonal antibody against human insulin-like growth factor binding protein-1, functionally interfering with insulin-like growth factor binding. Growth Regul (1993) 0.76
A new polymorphic probe on chromosome 22q: NB129 (D22S193). Nucleic Acids Res (1991) 0.75
A new polymorphic probe on chromosome 22: NB84 (D22S183). Nucleic Acids Res (1991) 0.75
A new polymorphic probe on chromosome 22: NB35 (D22S182). Nucleic Acids Res (1991) 0.75
A new polymorphic probe on chromosome 22: NB5 (D22S201). Nucleic Acids Res (1991) 0.75
Studies of the producer cell of herpes simplex virus-induced interferon in mouse spleen cell cultures. Immunobiology (1980) 0.75
Interferon production in the human mixed lymphocyte culture. Transplantation (1981) 0.75
An in vitro model of intra-epithelial expansion of transformed urothelial cells. Int J Cancer (1993) 0.75
Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries. Regul Pept (1993) 0.75
Molecular cloning of a macrophage-derived, interferon-inducible secreted immunoglobulin-binding protein. Eur J Immunol (1999) 0.75
Interferon-induced expression of If-1h and If-1l alleles in Newcastle disease virus-infected mouse macrophages is associated with specific differences in viral gene transcription. J Interferon Cytokine Res (1998) 0.75